Market Size of Japan Diagnostic Imaging Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 6.28 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Japan Diagnostic Imaging Services Market Analysis
The Japan Diagnostic Imaging Market is projected to register a CAGR of 6.28% over the forecast period (2022-2027).
The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. However, with the advent of the COVID-19 infection, lung imaging became a major part of COVID-19 diagnostics, as it helped diagnose the severity of the disease in the affected population. For instance, an article titled 'Computed tomography surveillance helps tracking COVID-19 outbreak' published in the Japanese Journal of Radiology in December 2020 indicated that a computed tomography surveillance program (CT-surveillance) could demonstrate the epidemiologic features of COVID-19 infection. Such activities helped the growth of the market during the COVID-19 pandemic.
The major factors augmenting the growth of the diagnostic imaging market in Japan include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and the rise in the geriatric population.
According to the Statistics Bureau of Japan, the country is experiencing a 'super-aging' society both in rural and urban areas. As per the February 2021 article by the Public Relations Office of the Government of Japan, the percentage of people over the age of 65 years old in Japan is expected to reach 33.3% by the year 2036 and 38.4% by the year 2065. Moreover, the prevalence of chronic diseases is also increasing among the Japanese population, and more so among the geriatric population as they are more prone to diseases. But Japan is a developed country that has a developed healthcare system as well. The healthcare industry in Japan has well adopted new innovations and advancements for diagnosis. These factors have helped this diagnostic imaging market grow in Japan.
An article titled 'Developing diagnostic reference levels in Japan' published in the Japanese Journal of Radiology in November 2021 indicated that the use of radiological tests in the nation has been increasing significantly in recent years. The article also aimed at developing an infrastructure for the review of diagnostic references in the nation. Such activities are likely to propel the growth of the market over the forecast period.
However, the cost of diagnosis due to expensive instruments and side effects that follow the diagnostic imaging have been restraining the growth of this market.
Japan Diagnostic Imaging Services Industry Segmentation
As per the scope of the report, the diagnostic imaging market covers a wide array of medical devices used for diagnostic purposes. In the report, a detailed analysis of the diagnostic imaging market in Japan is provided. The market is segmented by Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Other Applications), and End-user (Hospitals, Diagnostic Centers and Others). The report offers the value (in USD million) for the above segments.
By Modality | |
MRI | |
Computed Tomography | |
Ultrasound | |
X-Ray | |
Nuclear Imaging | |
Fluoroscopy | |
Mammography |
By Application | |
Cardiology | |
Oncology | |
Neurology | |
Orthopedics | |
Gastroenterology | |
Gynecology | |
Other Applications |
By End User | |
Hospitals | |
Diagnostic Centers | |
Others |
Japan Diagnostic Imaging Market Size Summary
The Japan Diagnostic Imaging Services Market is experiencing significant growth, driven by several key factors. The rise in chronic diseases and the increasing geriatric population are major contributors to this expansion. As Japan navigates a 'super-aging' society, the demand for advanced medical imaging technologies has surged, facilitating early diagnosis and treatment. The healthcare system's adaptability to innovations has further bolstered market growth. The COVID-19 pandemic, while challenging, also played a role in market expansion as lung imaging became crucial for diagnosing the virus's severity. This period saw increased adoption of computed tomography surveillance, which highlighted the epidemiological features of COVID-19, thereby enhancing the market's trajectory.
The oncology segment is poised for substantial growth due to the rising incidence of cancer and technological advancements in diagnostic imaging. The demand for clinical diagnostic imaging is expected to increase as healthcare providers seek effective surgical and non-surgical treatment options. The market is also witnessing the introduction of advanced diagnostic equipment by key players, such as Philips and Konica Minolta, which are enhancing product offerings and geographical presence. These developments, coupled with the implementation of hybrid medical devices like PET/CT and PET/MRI, are expected to sustain the market's growth momentum. Despite challenges such as high diagnostic costs and potential side effects, the market's outlook remains positive, supported by ongoing innovations and strategic acquisitions by leading vendors.
Japan Diagnostic Imaging Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing geriatric poulation
-
1.2.2 Increased adoption of diagnostic imaging by the medical industry
-
1.2.3 Technological advances and rapid innovation
-
1.2.4 Increased incidence of chronic diseases
-
-
1.3 Market Restraints
-
1.3.1 Expensive procedures and equipment
-
1.3.2 Side effects of diagnostic imaging procedures
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
-
2.1 By Modality
-
2.1.1 MRI
-
2.1.2 Computed Tomography
-
2.1.3 Ultrasound
-
2.1.4 X-Ray
-
2.1.5 Nuclear Imaging
-
2.1.6 Fluoroscopy
-
2.1.7 Mammography
-
-
2.2 By Application
-
2.2.1 Cardiology
-
2.2.2 Oncology
-
2.2.3 Neurology
-
2.2.4 Orthopedics
-
2.2.5 Gastroenterology
-
2.2.6 Gynecology
-
2.2.7 Other Applications
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Diagnostic Centers
-
2.3.3 Others
-
-
Japan Diagnostic Imaging Market Size FAQs
What is the current Japan Diagnostic Imaging Market size?
The Japan Diagnostic Imaging Market is projected to register a CAGR of 6.28% during the forecast period (2024-2029)
Who are the key players in Japan Diagnostic Imaging Market?
Canon Medical Systems Corporation, Fujifilm Holdings, GE Healthcare, Philips Healthcare and Siemens Healthcare are the major companies operating in the Japan Diagnostic Imaging Market.